Introduction
Acinetobacter is one of the important nosocomial pathogens and has been known to cause different kinds of opportunistic infections. 1 These gram negative coccobacilli are ubiquitous in nature, responsible for causing intermittent outbreaks especially in regions where temperature is hot and humid. Infections caused by them are difficult to control due to multidrug resistance, which limits therapeutic options in critically ill and debilitated patients, especially from the intensive care units (ICU), where prevalence of the organism is the most noted. 2 Acinetobacter baumannii is now recognized to be the species of great clinical importance being capable of causing lifethreatening infections including pneumonia, septicemia, wound sepsis, urinary tract infection, endocarditis and meningitis. 3 Also it is currently the most common isolate from gram negative sepsis in immunocompromised patients posing risk for high mortality. 4 The organism prefers moist environment, therefore, its colonization among damaged tissues is common. 5 It is very difficult to explain the role of Acinetobacter acquisition in the ICU, since the organism does not always act as an infecting pathogen, as it is widely distributed in nature and has tremendous colonizing potential. 1, 6 Also there is a significant difference in the behaviour of this organism among isolates recovered from various geographic locations. 7 In addition, risk factor for Acinetobacter acquisition, may vary in different set-ups with epidemic outbreaks of infection or endemic colonization. 8 Although various factors predisposing to Acinetobacter infection have been analyzed in different studies, there are only few authentic reports from India that have attempted to determine the risk factors and in vitro susceptibility and resistance patterns of clinically significant Acinetobacter isolates. 9, 10, 11 The present study describes the experiences with clinical materials and cases from which the strains of Acinetobacter were isolated and to determine the resistance pattern of Acinetobacter isolates to various antimicrobial agents by disc diffusion method and micro-broth dilution method obtained from a tertiary care hospital.
Methods
After taking approval from the hospital ethical committee, the study was carried out in a 600-bed tertiary care hospital, the Sheri Kashmir Institute of Medical Sciences, located in North India during 2 years period (June, 2001 through June, 2003). Nosocomially acquired Acinetobacter infection was defined as the case from which isolation of the organism was done repeatedly from blood cultures and other specimens, 72 hours following a patient was admitted to the hospital. Standard definitions as given by Centre for Disease Control and Prevention were used to differentiate categories of infection versus colonization. 13 In brief, patients from whom Acinetobacter was isolated in absence of clinical disease suggested colonization and were not included in the study. Clinical specimens included were blood, CSF, endotracheal aspirate, urine, sputum, pus and other body fluids like pleural and peritoneal fluids. The following variables were analyzed: patient age, sex, and the presence of underlying diseases or conditions, admission to ICU, mechanical ventilation, urinary and intravenous (IV) catheterization, number of hospital days and surgery, if any.
All clinical specimens were initially processed by the routine microbiological and biochemical tests. Typical colonies were enumerated, picked and examined further. Acinetobacter was identified by gram-staining, cell and colony morphology, activity of oxidation/ fermentation tests, absence of motility and negative oxidase and positive catalase tests. Speciation of Acinetobacter into various genomic species (GS) was done by using a battery of bio-chemical tests. 14 Disc diffusion susceptibility testing was performed on Mueller-Hinton agar for following anti-microbial agents with their concentrations given in parentheses: Ampicillin (10µg), Amikacin (30µg), Gentamicin (10µg), Ciprofloxacin (5µg), Ofloxacin (5µg), Cefazolin (30µg), Cefotaxime (30µg), Cefoperazone+Sulbactam (75µg) and Imipinem (10µg). Strains found resistant to various antimicrobials by disc diffusion method were tested by NCCLS broth micro-dilution method. 15 Pseudomonas aeroginosa ATCC 27853 was used as the control strain.
The difference in the risk-factors among patients with Acinetobacter infection and patients with other gramnegative bacterial infections were compared and investigated for significant risk factors in patients with these infections. Contingency tables were calculated with Pearson's test of Fischer's exact test by comparing the proportions, wherever necessary. The differences were considered to be significant if the p-value associated with the test was less than 0.05. For all the analysis, the SPSS software, version 10.0 was used.
Results
During the study period, 25,200 samples were cultured, of which 5352 (21.23%) were found to be infected. Out of these infected samples, 258 (4.8%) were found to be due to Acinetobacter.
The patients ranged in age from 18 days to 84 years (Mean age ± SD, 33.2± 22.8 years, median age 42 years). (Table I) Acinetobacter was isolated from various types of infections; among these, urinary tract infections were extremely www.bjmm.org.bd Bangladesh J Med Microbiol Volume 3: Number 1 January, 2009 significant (p<0.0001), followed by pus and wound exudates (p<0.05). Also, 17% of the bacteremic cases were associated with catheterization, about 50% of them had undergone surgery and 24% had been intubated and ventilated.
Acinetobacter infection was significantly observed (p<0.05) in intensive care unit and patients on mechanical ventilation. Also, a longer stay in hospital that is beyond the first week was significantly associated with a remarkably higher rate of infection (p<0.0001). However, no statistically significant association was found in relation to age, sex and surgery.
A. baumanni was the main species responsible for 72% of the infections followed by A. calcocaeticus and A. junii (10.6% and 7.5 % respectively). A. lwoffii and A. haemolyticus were predominantly found in wound exudates. Strains of A. baumainnii were found to be more resistant to all antibiotics as compared to other Acinetobacter species. The range of MIC results obtained were found highly elevated in isolates. The highest resistance was observed in ICU isolates, where A. baumanni was most prevalent. (Table  III) 
Discussion
Acinetobacter has emerged as an important nosocomial pathogen, often with a rising prevalence of multidrug resistance and are associated with life-threatening infections. 15, 16 The overall incidence of Acinetobacter from all infective samples was 4.8 % ( 258 out of 5352) indicating its importance as a nosocomial pathogen, since in most of the cases the patients were symptomatic for sepsis. There was a significantly higher incidence of infection among males which is in tandem with other studies from India. 12 The literature search demonstrates that A. baumannii together with A. calcoaceticus; GS3, GS13 (Genomic species 3 and 13) are predominantly involved in infection and are collectively known as A. calcoaceticus-A. baumannii (Acb) complex group. 17 A. baumanni was the major species isolated from 72% of the clinical samples in the present study, is reportedly a major species in other parts of the world as well. 7 In the current study, the maximum number of isolates was from the urinary tract (39.64%) and these were the strains that showed maximum multidrug resistance. These results are comparable to some of the studies done previously. 2 About 15% of these isolates were associated with the use of indwelling catheters and 30% of the patients had serious underlying debilitating diseases. The incidence of respiratory tract infection was 14.7%. Mechanical ventilation and admission to ICU were found to be independent risk factors for these infections. Bacteremia is known to be associated with risk factors like intravenous catheterization. 19 Overall, in the present study, the significant risk factors for Acinetobacter infection were mechanical ventilation, admission to ICU, underlying chronic debilitating condition and a prolonged hospital stay. A longer stay in a high risk unit and use of mechanical ventilation has been identified as a risk factor in previous studies as well. 17, 19, 20 Despite many intensive efforts, the nosocomial acquisition of Acinetobacter remains problematic especially in the ICUs. There are difficulties in control of infections due to their high resistance to antimicrobials in the hospital environment. Exposure to certain antibiotics provides a selective advantage to a small number of resistant organisms in patients already colonized, thereby enabling them to turn into pathogens.
Susceptibilities of Acinetobacter against various antimicrobials being considerably different among countries, centres and even among different wards of the same hospital, therefore, such type of local surveillance studies are found important in deciding the most adequate therapy for Acinetobacter infection. 2 The high-level resistance of Acinetobacter to antimicrobials seems inevitable. 22 Only a few authentic data are available regarding in vitro susceptibility of clinical isolates of A. baumannii in India. 23 Increasing resistance to Cephalosporins was observed mainly in strains belonging to the Acb complex. Amikacin, Cefoperazone+Sulbactam and Imipinem showed maximum level of activity with susceptibilities of 83%, 87.5% and 98.5% respectively. This susceptibility pattern conforms to the recent introduction of these antibiotics in the hospital where the present study was carried out. The MIC range of presently isolated strains was higher than many other recent reports. 19, 22 This means multi-drug resistant (MDR) isolates are increasing day by day, probably due to indiscriminate use of these antibiotics in healthcare settings. It is re-emphasized that broad-spectrum antibiotics should be used with caution. Cefotaxime, and/or Ceftriaxone should be discontinued in units where resistant strains for these two antibiotics are being reported. With revealation of Cefotaxime and/or Ceftriaxone-resistant strains from this study, the hospital ICU was advised to use other antibiotic combinations like effective beta lactams or Carbapenem along with Amikacin.
In conclusion, the MDR A. baumannii was the species responsible for majority of Acinetobacter infection in the hospital under study. Mechanical ventilation and admission to ICU were found to be potential independent risk factors in the setup investigated. Strict infection control measures may prevent nosocomial infections. Further research related to mechanism of resistance and extended spectrum betalactamases and Carbapenem is underway.
